-
Markets
-
Equities
Sustainable finance2025 Euronext ESG Trends ReportRead moreA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesRead moreThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETFs
The European market place for ETFsEuronext ETF EuropeRead moreInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Funds
-
Fixed Income
European Defence BondsGroupe BPCE lists the first bondRead moreFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Structured Products
-
Derivatives
Where European Government Bonds Meet the FutureFixed Income derivativesRead moreTrade mini bond futures on main European government bonds
-
Commodities
- Overview
- Quotes snapshot
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Delivery & settlement
- Specifications & arrangements
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesRead moreEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Resources
Designed to help students navigate the complexities of financial marketsEuronext Trading gameRead moreJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
2024 Annual Report Vistin Pharma ASA
25 Apr 2025 16:40 CEST
Issuer
Vistin Pharma ASA
Oslo, Norway, 25 April 2025
Please find attached the Annual Report for 2024 for Vistin Pharma ASA (VISTN).
There are no material changes in the financial statements compared to the
preliminary full year results presented on 13 February 2025.
The annual report for 2024 will also be made available on www.vistin.com
(http://www.vistin.com).
*****
For further information, please contact:
Alexander Karlsen
CFO
+47 97 05 36 21
Alexander.karlsen@vistin.com (mailto:Alexander.karlsen@vistin.com)
This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.
More information:
Access the news on Oslo Bors NewsWeb site
644487_Annual Report 2024 Vistin Pharma ASA.pdf
644487_Vistinpharmaasa-2024-12-31-0-en.zip
Source
Vistin Pharma ASA
Provider
Oslo Børs Newspoint
Company Name
VISTIN PHARMA
ISIN
NO0010734122
Symbol
VISTN
Market
Euronext Oslo Børs